What looks like Canada’s most promising premium marijuana brand has recently received a license to produce medical marijuana. The brand hasn’t yet acquired the licensing need to sell marijuana, but will likely receive the go-ahead after necessary government testing.
Hydropothecary’s co-founder Adam Miron says that there is still unmet demand in Canada, most notably in high-quality marijuana. The Quebec-based company has been around for a little over a year and a half, but has already begun branding their product and the experience they hope to offer customers.
With premium products come premium prices.
The company has created what looks to be 4 distinct experiences with their product, all priced at 2 to 3 times higher than what other retailers might charge for a gram. Ranging from $26 a gram to $32 a gram, the company offers a different strain for every part of the day.
From their packaging previews, each one-gram sample looks akin to what craft brewers or Scotch lovers might receive in holiday gift set. The discreet boxes and velvet lined interiors could be mistaken for jewelry boxes.
The pricing will be justified in their superior customer service. Hydropothecary’s Adam Miron says the company guarantees supply, delivery, and around-the-clock service. For Canadian medical marijuana patients looking for premium product and guaranteed access to their meds, this could be the go-to.
Though not yet permitted to sell, it is likely that the company will receive approval to dispense medicine in the next two months. With their grows in progress now, their By The Bud website says they will be ready to go just 77 days from right now. That’s just enough time to turn around a quick harvest.
As the medical marijuana industry becomes more saturated in North America, discerning consumers will likely demand the option of premium products and the premium branding that comes along with it. It looks like Hydropothecary will be there to meet those demands.
via: Ottawa Citizen